News

Researchers from the University of Pittsburgh have reported two nanoscale devices (recently in two separate journals) harness the potential of carbon nanomaterials to enhance technologies for drug or

The Valspar Corporation has reported its results for the third-quarter ended July 31, 2009. The company’s third-quarter sales totaled $794.6m, 17% lower than sales in the third quarter

Santhera has reported that it has exercised its option to acquire Oy Juvantia Pharma, the owner of JP-1730/fipamezole. Reportedly, the company will issue up to 105,973 previously reserved

Vasogen and IntelliPharmaCeutics (IPC) have entered into a definitive agreement, subject to shareholder and regulatory approvals. As per the deal, Vasogen will combine with IPC under a plan

DATATRAK International has reported a decrease in revenue by 19% or $0.41m to $1.8m for the second quarter ended June 30, 2009, compared to $2.2m for the same

FDA has approved Protalix BioTherapeutics’ treatment protocol for prGCD, the proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD), for the treatment of Gaucher disease. The treatment protocol allows

BioSante Pharmaceuticals has presented H1N1 vaccine results at the Immunotherapeutics & Vaccine Summit in Providence, RI. BioSante claims that its vaccine adjuvant – BioVant has increased the protective

Par Pharmaceutical has announced that the US District Court for the District of Delaware has ruled in favor of Par in its challenge of Purdue’s patents relating to

Covidien has launched the NeoMode software upgrade for the Puritan Bennett 840 ventilator, an improvement designed to help clinicians better manage neonate patients. The NeoMode software upgrade enables